Open Actively Recruiting

Psychoeducation for Uveal Melanoma

About

Brief Summary

This clinical trial evaluates a video-based psychoeducational intervention for patients with uveal melanoma. Uveal melanoma (UM) is a rare intraocular cancer. UM patients face an uncertain course of survivorship in terms of their visual acuity, treatment-related side effects, and risk for eventual metastasis of the cancer. Learning about patients' thoughts and reactions to informational resources may better support patients during ocular melanoma survivorship.

Study Type
Observational
Phase
N/A

Eligibility

Gender
All
Healthy Volunteers
No
Minimum Age
18 Years
Maximum Age
N/A

Inclusion Criteria:

  • Adults (age 18 years and older at visit 1)
  • History of uveal melanoma as documented in their University of California, Los Angeles (UCLA) medical record
  • Receipt of uveal melanoma treatment and/or ongoing follow-up care at the UCLA Jules Stein Eye Institute, as documented in their UCLA medical record
  • Ability to read, write, and converse in English
  • Access to the internet via a computer or cell phone
  • Access to a personal email address
  • Written informed consent obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study

Exclusion Criteria:

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
23-000414
Category
Head and Neck Cancer
Principal Investigator
Annette Stanton
Contact
Megan Hoch
Location
  • UCLA Westwood
For Providers
NCT No.
NCT06075589
For detailed technical eligibility, visit ClinicalTrials.gov.